ACLA Urges FDA to Reconsider Recent PGx Enforcement Moves - 360Dx

Submitted by Anonymous (not verified) on Thu, 09/19/2019 - 14:45

ACLA Urges FDA to Reconsider Recent PGx Enforcement Moves  360DxThe industry organization issued a letter urging the agency to reconsider recent decisions to demand several laboratories stop offering pharmacogenetic testing.